United States · FDA National Drug Code directory
Brimonidine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61314-143_d30b64a2-52a4-4c29-bb4e-64cd0444127b
- Product NDC
- 61314-143
- Form
- SOLUTION
- Composition / generic term
- Brimonidine Tartrate
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20030917
- Source listing expiry
- 20261231
Source-listed ingredients
- BRIMONIDINE TARTRATE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (61314-143-05) / 5 mL in 1 BOTTLE · 61314-143-05
- 1 BOTTLE in 1 CARTON (61314-143-10) / 10 mL in 1 BOTTLE · 61314-143-10
- 1 BOTTLE in 1 CARTON (61314-143-15) / 15 mL in 1 BOTTLE · 61314-143-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →